Connection
Tarak Srivastava to Bone Diseases, Metabolic
This is a "connection" page, showing publications Tarak Srivastava has written about Bone Diseases, Metabolic.
|
|
Connection Strength |
|
 |
|
 |
|
0.388 |
|
|
|
-
VanSickle JS, Srivastava T, Alon US. Use of calcimimetics in children with normal kidney function. Pediatr Nephrol. 2019 03; 34(3):413-422.
Score: 0.155
-
Sebestyen JF, Srivastava T, Alon US. Bisphosphonates use in children. Clin Pediatr (Phila). 2012 Nov; 51(11):1011-24.
Score: 0.106
-
Waterhouse KM, Auron A, Srivastava T, Haney C, Alon US. Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children. Pediatr Nephrol. 2007 Feb; 22(2):282-7.
Score: 0.070
-
Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr. 2003 Nov; 162(11):735-51.
Score: 0.057